GDRX Relative Valuation
GDRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GDRX is overvalued; if below, it's undervalued.
Historical Valuation
GoodRx Holdings Inc (GDRX) is now in the Fair zone, suggesting that its current forward PS ratio of 2.07 is considered Fairly compared with the five-year average of 111.21. The fair price of GoodRx Holdings Inc (GDRX) is between 3.86 to 5.68 according to relative valuation methord.
Relative Value
Fair Zone
3.86-5.68
Current Price：4.40
Fair
25.88
PE
1Y
3Y
5Y
Trailing
Forward
6.88
EV/EBITDA
GoodRx Holdings Inc. (GDRX) has a current EV/EBITDA of 6.88. The 5-year average EV/EBITDA is 26.62. The thresholds are as follows: Strongly Undervalued below -24.88, Undervalued between -24.88 and 0.87, Fairly Valued between 52.37 and 0.87, Overvalued between 52.37 and 78.12, and Strongly Overvalued above 78.12. The current Forward EV/EBITDA of 6.88 falls within the Historic Trend Line -Fairly Valued range.
9.02
EV/EBIT
GoodRx Holdings Inc. (GDRX) has a current EV/EBIT of 9.02. The 5-year average EV/EBIT is 30.91. The thresholds are as follows: Strongly Undervalued below -27.61, Undervalued between -27.61 and 1.65, Fairly Valued between 60.18 and 1.65, Overvalued between 60.18 and 89.44, and Strongly Overvalued above 89.44. The current Forward EV/EBIT of 9.02 falls within the Historic Trend Line -Fairly Valued range.
2.06
PS
GoodRx Holdings Inc. (GDRX) has a current PS of 2.06. The 5-year average PS is 8.07. The thresholds are as follows: Strongly Undervalued below -8.11, Undervalued between -8.11 and -0.02, Fairly Valued between 16.16 and -0.02, Overvalued between 16.16 and 24.25, and Strongly Overvalued above 24.25. The current Forward PS of 2.06 falls within the Historic Trend Line -Fairly Valued range.
8.25
P/OCF
GoodRx Holdings Inc. (GDRX) has a current P/OCF of 8.25. The 5-year average P/OCF is 15.69. The thresholds are as follows: Strongly Undervalued below -116.79, Undervalued between -116.79 and -50.55, Fairly Valued between 81.93 and -50.55, Overvalued between 81.93 and 148.16, and Strongly Overvalued above 148.16. The current Forward P/OCF of 8.25 falls within the Historic Trend Line -Fairly Valued range.
9.48
P/FCF
GoodRx Holdings Inc. (GDRX) has a current P/FCF of 9.48. The 5-year average P/FCF is 38.18. The thresholds are as follows: Strongly Undervalued below -45.49, Undervalued between -45.49 and -3.65, Fairly Valued between 80.02 and -3.65, Overvalued between 80.02 and 121.86, and Strongly Overvalued above 121.86. The current Forward P/FCF of 9.48 falls within the Historic Trend Line -Fairly Valued range.
GoodRx Holdings Inc (GDRX) has a current Price-to-Book (P/B) ratio of 2.50. Compared to its 3-year average P/B ratio of 3.04 , the current P/B ratio is approximately -17.73% higher. Relative to its 5-year average P/B ratio of 8.15, the current P/B ratio is about -69.34% higher. GoodRx Holdings Inc (GDRX) has a Forward Free Cash Flow (FCF) yield of approximately 8.71%. Compared to its 3-year average FCF yield of 6.80%, the current FCF yield is approximately 28.22% lower. Relative to its 5-year average FCF yield of 4.82% , the current FCF yield is about 80.68% lower.
2.42
P/B
Median3y
3.04
Median5y
8.15
8.77
FCF Yield
Median3y
6.80
Median5y
4.82
Competitors Valuation Multiple
The average P/S ratio for GDRX's competitors is 1.28, providing a benchmark for relative valuation. GoodRx Holdings Inc Corp (GDRX) exhibits a P/S ratio of 2.06, which is 60.37% above the industry average. Given its robust revenue growth of 2.57%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of GDRX decreased by 44.43% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 4.98 to 60.89.
The secondary factor is the Revenue Growth, contributed 2.57%to the performance.
Overall, the performance of GDRX in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is GoodRx Holdings Inc (GDRX) currently overvalued or undervalued?
What is GoodRx Holdings Inc (GDRX) fair value?
How does GDRX's valuation metrics compare to the industry average?
What is the current P/B ratio for GoodRx Holdings Inc (GDRX) as of Aug 06 2025?
What is the current FCF Yield for GoodRx Holdings Inc (GDRX) as of Aug 06 2025?
What is the current Forward P/E ratio for GoodRx Holdings Inc (GDRX) as of Aug 06 2025?